Project Grant R00CA287045
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Johns Hopkins University a $144,193 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) effective September 4, 2025 through August 31, 2030. This award provides protected salary support for Dr. Preethi Korangath to serve as a Laboratory Research Specialist in Dr. Robert Ivkov's laboratory, where she will facilitate the completion of Research Project Grants (R01) by leveraging her expertise...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a $512,728 Project Grant effective August 1, 2025, through May 31, 2030, under the Cancer Detection and Diagnosis Research Program (CFDA 93.394). The award supports development and clinical evaluation of PROBOT, a novel ultrasound probe and robotic system designed to improve image-guided interventions for prostate cancer diagnosis and treatment. The project encompasses a Phase 1...
- Federal Grant Award Summary New York University School of Medicine received a $681,215 Project Grant award from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) beginning September 1, 2025 and concluding August 31, 2030. The project aims to develop artificial intelligence (AI)-enabled magnetic resonance (MR) imaging technology to support point-of-care prostate cancer detection at the population level. The research challenges conventional...
- Federal Project Grant Award Summary The National Cancer Institute awarded a $477,674 Project Grant to The Johns Hopkins University (Baltimore, MD) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to conduct molecular imaging research focused on understanding the immune-suppressive tumor microenvironment (TME) in prostate cancer and its response to immune checkpoint inhibitor (CIT) therapy. The research initiative, effective June 1, 2026 through May 31, 2031, will deliver...
- Federal Grant Award Summary The National Cancer Institute awarded a $371,161 Project Grant to the University of Colorado-Denver under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) on September 1, 2025, for a two-year performance period concluding August 31, 2027. The award funds the development of artificial intelligence (AI) algorithms designed to improve cervical cancer screening in low-resource settings. Specifically, the project will create advanced AI risk stratification...
- Federal Grant Award Summary The National Cancer Institute awarded a $640,956 Project Grant to the University of California, Los Angeles (UCLA) under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) to develop an artificial intelligence (AI)-enhanced perfusion magnetic resonance imaging (MRI) tool for optimizing yttrium-90 (Y-90) particle distribution in radioembolization treatment of liver cancer. The project, which commenced May 15, 2026 and extends through April 30, 2031, aims...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a Project Grant totaling $130,301 on September 5, 2025, under the Cancer Cause and Prevention Research program (CFDA 93.393). The award supports research extending the Surveillance, Epidemiology, and End Results (SEER)-Medicare Database, a critical population-based health services resource that links Medicare claims data with cancer registry enrollment information. The research will leverage...
- Federal Grant Award Summary The National Cancer Institute awarded Johns Hopkins University a $591,419 project grant under the Cancer Treatment Research program (CFDA 93.395) effective May 1, 2026 through April 30, 2031. The award supports the development of low molecular weight theranostics targeting multiple myeloma, a disease characterized by malignant plasma cell expansion in the bone marrow. The research addresses critical gaps in treating therapy-resistant myeloma by developing a...
- Federal Project Grant Award Summary The University of Chicago received a $249,000 Project Grant award from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) effective April 1, 2026, through March 31, 2029. The grant funds the development of explainable artificial intelligence (AI) models to predict early-stage melanoma recurrence by integrating multiplexed tissue imaging, spatial transcriptomics, and histopathological data. The research...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded The Johns Hopkins University a $399,129 Project Grant under the Cancer Treatment Research program (CFDA 93.395) on July 15, 2025, with a completion date of June 30, 2027. This award supports research to develop and evaluate improved cancer treatment methods through laboratory and clinical investigation. Specifically, the research leverages a DDX3 inhibitor called RK-33 to alter the metabolic tumor environment in...
The National Cancer Institute awarded a $249,000 Project Grant to The Johns Hopkins University under the Cancer Detection and Diagnosis Research Program (CFDA 93.394) for a three-year project period from January 1, 2026 through December 31, 2028. The project, titled "Large-Scale Artificial Intelligence Using Radiomics, Deep Learning, and Physics-Based Generative Modeling to Improve Clinical Outcomes in Nuclear Medicine," addresses critical challenges in applying artificial intelligence and deep learning methodologies to cancer detection and diagnosis within nuclear medicine imaging. The research deliverables include three primary components: (1) development of a large-scale clinical database of Positron Emission Tomography/Computed Tomography (PET/CT) images with physician-annotated ground truth to support machine learning model training; (2) creation of a physics-guided deep generative modeling approach to generate realistic simulated PET/CT data with known ground truth, thereby expanding training datasets without the constraints of limited annotated clinical data; and (3) quantification of radiomic feature robustness to address reproducibility challenges stemming from scanner variability, reconstruction methods, and operator-dependent segmentation differences. These integrated deliverables are designed to advance reproducible, generalizable AI-based diagnostic tools that improve early cancer detection and clinical outcomes through enhanced analysis of nuclear medicine imaging data.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 4/17/26 |